Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Resnick

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Archives of Internal Medicine|May 24, 1993
The consent form revisitedJ Sloan, G D Resnick
Blood|February 1, 1981
Reed-Sternberg cells in Hodgkin's disease contain fibronectinG D Resnick, R L Nachman
The American Journal of Pathology|July 1, 1973
On the virulence of group A streptococci: evidence for virulence factors other than M-protein and capsuleC G Becker, G D Resnick, S Shustak
Seminars in Oncology|February 1, 1997
Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanomaJ M Kirkwood, G D Resnick, B F Cole
Blood|July 1, 1979
Variant ph1 translocation in chronic myeloid leukemiaJ D Rowley, G D Resnick, S L Whitman, et al.
Cancer|February 1, 1995
Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup studyL I Gordon, J Andersen, J Colgan, et al.
The New England Journal of Medicine|November 5, 1992
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphomaL I Gordon, D Harrington, J Andersen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Archives of Internal Medicine|May 24, 1993
The consent form revisitedJ Sloan, G D Resnick
Blood|February 1, 1981
Reed-Sternberg cells in Hodgkin's disease contain fibronectinG D Resnick, R L Nachman
The American Journal of Pathology|July 1, 1973
On the virulence of group A streptococci: evidence for virulence factors other than M-protein and capsuleC G Becker, G D Resnick, S Shustak
Seminars in Oncology|February 1, 1997
Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanomaJ M Kirkwood, G D Resnick, B F Cole
Blood|July 1, 1979
Variant ph1 translocation in chronic myeloid leukemiaJ D Rowley, G D Resnick, S L Whitman, et al.
Cancer|February 1, 1995
Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup studyL I Gordon, J Andersen, J Colgan, et al.
The New England Journal of Medicine|November 5, 1992
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphomaL I Gordon, D Harrington, J Andersen, et al.
Pageof 1